Search Results1-7 of  7

  • NAGASHIMA MASAHITO ID: 9000256797951

    Department of Microbiology, School of Medicine, Toho University (1996 from CiNii)

    Articles in CiNii:1

    • IN VITRO AND IN VIVO ACTIVITIES OF SULOPENEM COMPARED WITH THOSE OF IMIPENEM AND CEPHALOSPORINS (1996)
  • NAGASHIMA Masahito ID: 9000000298920

    ファイザー株式会社 (2012 from CiNii)

    Articles in CiNii:5

    • IN VITRO AND IN VIVO ACTIVITIES OF SULOPENEM COMPARED WITH THOSE OF IMIPENEM AND CEPHALOSPORINS (1996)
    • Japan vs. Europe comparison of clinical evaluation methods for new antimicrobial drugs: on the difference in chronic airway infection cases between Ireland and Japan (2000)
    • New Evidence for Anti-Pseudomonal Activity of Macrolides : Exposure- Dependent Accumulation and Inhibition of Protein Synthesis (1996)
  • NAGASHIMA Masahito ID: 9000018556171

    Pfizer Japan Inc (2011 from CiNii)

    Articles in CiNii:1

    • Criteria for safety evaluation of antimicrobial agents (2011)
  • NAGASHIMA Masahito ID: 9000022111046

    the Department of Internal Medicine, Kitami Red Cross Hospital (1993 from CiNii)

    Articles in CiNii:1

    • A Patient with Rheumatoid Arthritis Complicated by Sjoegren's Syndrome that was Possibly Caused by Reactivation of Epstein-Barr Virus. (1993)
  • Nagashima Masahito ID: 9000256464183

    Department of Microbiology, School of Medicine, Toho University (1995 from CiNii)

    Articles in CiNii:1

    • <I>In vitro</I> and <I>in vivo</I> antibacterial activity of azithromycin, a new azalide antibiotic (1995)
  • Nagashima Masahito ID: 9000256466474

    Clinical Research (Infectious Disease), Pfizer Pharmaceutical Inc. (2000 from CiNii)

    Articles in CiNii:1

    • Japan vs. Europe comparison of clinical evaluation methods for new antimicrobial drugs. On the difference in chronic airway infection cases between Ireland and Japan.:On the difference in chronic airway infection cases between Ireland and Japan (2000)
  • Nagashima Masahito ID: 9000321621989

    Pfizer Japan Inc., Tokyo 151-8589, Japan (2016 from CiNii)

    Articles in CiNii:1

    • Efficacy and safety of monotherapy by pegvisomant, a growth hormone receptor antagonist, in Japanese patients with acromegaly (2016)
Page Top